Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PressureStim was a medical device company that developed a non-invasive, wearable solution for the treatment of hypertension. The company's technology utilized targeted mechanical stimulation of the carotid baroreceptors in the neck to activate the body's natural blood pressure regulation system, known as the baroreflex. Designed as a user-friendly wearable device, it aimed to provide a non-pharmacological and non-surgical alternative for patients with resistant or uncontrolled high blood pressure. Incubated by The Trendlines Group in Israel, the company conducted early-stage clinical pilot studies to validate its proprietary stimulation patterns and device ergonomics before becoming inactive.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PressureStim.